Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Tomas, Milota"'
Publikováno v:
Gastrointestinal Disorders, Vol 5, Iss 1, Pp 52-67 (2023)
Primary antibody deficiencies (PADs) are the most frequent group of inborn errors of immunity. Impaired B-cell development, reduced production of immunoglobulins (mainly IgG and IgA), and specific antibodies resulting in recurrent infections are thei
Externí odkaz:
https://doaj.org/article/716f3617811e4e4d85e301003321f88b
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionFibrodysplasia ossificans progressiva (FOP) is characterized by progressive heterotopic ossification triggered by various conditions, such as trauma, infection, including COVID-19 infection, and vaccination. Although SARS-CoV-2 vaccinatio
Externí odkaz:
https://doaj.org/article/d90dfa0792d84069b304195bd57f5562
Autor:
Jitka Smetanova, Tomas Milota, Michal Rataj, Jana Hurnakova, Hana Zelena, Anna Sediva, Rudolf Horvath
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundVaccination confers relatively short-term protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), indicating the need for booster doses. Immunocompromised individuals, including those with immune-mediated inflammato
Externí odkaz:
https://doaj.org/article/4f27f353b9f24f58b255d8a6d4af69c7
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Patients with STAT1 gain-of-function (GOF) mutations suffer from an inborn error of immunity hallmarked by chronic mucocutaneous candidiasis (CMC). The pathogenesis behind this complex and heterogeneous disease is still incompletely understood. Beyon
Externí odkaz:
https://doaj.org/article/ff55e25e2d0344048322da674f0ed1b3
Autor:
Zeinab A. El-Sayed, MD, PhD, Dalia H. El-Ghoneimy, MD, PhD, José A. Ortega-Martell, MD, Nesrine Radwan, MD, PhD, Juan C. Aldave, MD, Waleed Al-Herz, MD, Maryam A. Al-Nesf, MD, ABHS, Antonio Condino-Neto, MD, PhD, Theresa Cole, MD, PhD, Brian Eley, MD, Nahla H.H. Erwa, DipRCPATH, Sara Espinosa-Padilla, PhD, Emilia Faria, MD, Nelson A. Rosario Filho, MD, PhD, Ramsay Fuleihan, MD, Nermeen Galal, MD, PhD, Elizabeth Garabedian, RN, MSLS, Mary Hintermeyer, BN, Kohsuke Imai, MD, PhD, Carla Irani, MD, MSCE, Ebtihal Kamal, MD, Nadia Kechout, MD, PhD, Adam Klocperk, MD, PhD, Michael Levin, MD, PhD, Tomas Milota, MD, PhD, Monia Ouederni, MD, Roberto Paganelli, MD, Claudio Pignata, MD, PhD, Farah N. Qamar, MBBS, FCPS, MSc, DHPE, FRCP, Isabella Quinti, MD, PhD, Sonia Qureshi, MBBS, FCPS, MSc, Nita Radhakrishnan, MD, PhD, Nima Rezaei, MD, PhD, John Routes, MD, PhD, Surjit Singh, MD, DCH (Lon.), FRCP (Lon.), FRCPCH (Lon.), FAMS, Sangeetha Siniah, MBBS, MRCPCH, Intisar Abdel-Hakam Taha, MD, SMSB, Luciana K. Tanno, MD, Ph.D, Ben Van Dort, BN, Alla Volokha, MD, PhD, DSc, Kathleen Sullivan, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 6, Pp 100657- (2022)
Background: Allergies have long been observed in Inborn Errors of Immunity (IEI) and might even be the first presentation resulting in delayed diagnosis or misdiagnosis in some cases. However, data on the prevalence of allergic diseases among IEI pat
Externí odkaz:
https://doaj.org/article/cbea81132ac24929970ce980edc95b03
Autor:
Tomas Milota, Jana Hurnakova, Karel Pavelka, Zlatuse Kristkova, Lucie Nekvindova, Rudolf Horvath
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)
Introduction: The administration of biologic disease-modifying antirheumatic drugs, including tumor necrosis factor (TNF)-α inhibitors, is observed to interfere with the disease activity and progression. In this study, we aimed to assess the effecti
Externí odkaz:
https://doaj.org/article/51fdc92e7cbb480c9fe02c0414d1184c
Autor:
Tomas Milota, Marta Sobotkova, Jitka Smetanova, Marketa Bloomfield, Jana Vydlakova, Zita Chovancova, Jiri Litzman, Roman Hakl, Jiri Novak, Ivana Malkusova, Jana Hanzlikova, Dalibor Jilek, Beata Hutyrova, Vitezslav Novak, Irena Krcmova, Anna Sediva, Pavlina Kralickova
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Despite the progress in the understanding how COVID-19 infection may impact immunocompromised patients, the data on inborn errors of immunity (IEI) remain limited and ambiguous. Therefore, we examined the risk of severe infection course and hospital
Externí odkaz:
https://doaj.org/article/c9ffc8f2d5064127a039c58055a12895
Autor:
Martin Wasserbauer, Stepan Hlava, Milan Trojanek, Jan Stovicek, Tomas Milota, Jiri Drabek, Petra Koptová, Andrea Cupkova, Dita Pichlerová, Barbora Kucerova, Stepan Coufal, Radan Keil
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0273612 (2022)
Background and aimsSARS-CoV-2 is a worldwide serious health problem and vaccination seems to have a crucial role in managing the COVID-19 pandemic. The aim of this prospective observational study was to monitor the trend of antibodies against SARS-Co
Externí odkaz:
https://doaj.org/article/db4d72f702644faa8f81bd451ceeda4d
Publikováno v:
Pathogens, Vol 12, Iss 1, p 109 (2023)
In 2019, the novel coronavirus, SARS-CoV-2, caused a worldwide pandemic, affecting more than 630 million individuals and causing 6.5 million deaths. In the general population, poorer outcomes have been associated with older age, chronic lung and card
Externí odkaz:
https://doaj.org/article/e235d057225545488fb411c64cce1700
Autor:
John R. Hurst, S. Hamza Abbas, Heba M. Bintalib, Tiago M. Alfaro, Ulrich Baumann, Siobhan O. Burns, Alison Condliffe, Jesper R. Davidsen, Børre Fevang, Andrew R. Gennery, Filomeen Haerynck, Joseph Jacob, Stephen Jolles, Olivia Lamers, Anne Bergeron, Marion Malphettes, Véronique Meignin, Cinzia Milito, Tomas Milota, Martine Pergent, Antje Prasse, Isabella Quinti, Elisabetta Renzoni, Anna Sediva, Daiana Stolz, Bas Smits, Friedolin Strauss, Annick A.J.M. van de Ven, Joris van Montfrans, Klaus Warnatz
Publikováno v:
ERJ Open Research, Vol 7, Iss 4 (2021)
Externí odkaz:
https://doaj.org/article/7084a0aa8f714798a22a64d7160cde09